Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Augmedix Q2 2024 GAAP EPS $(0.16) Misses $(0.13) Estimate, Sales $13.664M Beat $13.636M Estimate

Author: Benzinga Newsdesk | August 12, 2024 04:02pm
Augmedix (NASDAQ:AUGX) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.13) by 23.08 percent. The company reported quarterly sales of $13.664 million which beat the analyst consensus estimate of $13.636 million by 0.20 percent. This is a 26.75 percent increase over sales of $10.780 million the same period last year.

Posted In: AUGX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist